Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Treatment algorithms for mood disorders].

Akihiko Oshima1, Kazuyuki Nakagome, Keiji Okimoto

  • 1Department of Psychiatry, Tatebayashi Kosei Hospital, 262-1, Narushima-cho, Tatebayashi, 374-8533 Japan.

Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology
|September 19, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Outcomes of Extended-Release Guanfacine in Adults With Attention-Deficit/Hyperactivity Disorder: A Retrospective Chart Review.

Cureus·2026
Same author

[EOSINOPHIL-ASSOCIATED DISEASES: A PATHOBIOLOGY-BASED, CROSS-ORGAN PERSPECTIVE].

Arerugi = [Allergy]·2026
Same author

Response to Durability of zuranolone in postpartum depression versus major depressive disorder.

Psychiatry and clinical neurosciences·2026
Same author

Safety and Effectiveness of Guanfacine Hydrochloride Extended-Release in Adult Patients with ADHD in Japan: A Post-Marketing Surveillance Study.

Advances in therapy·2026
Same author

Safety and efficacy of zuranolone in Japanese adults with major depressive disorder: An open-label, repeated-treatment part of a Phase 3 clinical trial.

PCN reports : psychiatry and clinical neurosciences·2026
Same author

Gray and White matter microstructural alterations in major depressive disorder: a multi-center diffusion imaging study.

Translational psychiatry·2026

This study reviews psychopharmacotherapy algorithms for bipolar depression, highlighting their evidence-based nature and global variations. Clinicians can personalize these guidelines through patient interaction.

Area of Science:

  • Psychiatry
  • Pharmacology
  • Evidence-Based Medicine

Context:

  • Psychopharmacotherapy algorithms are crucial for treating mental health conditions.
  • Existing algorithms offer a framework but require refinement.
  • International variations in treatment guidelines exist.

Purpose:

  • To summarize features and controversies surrounding psychopharmacotherapy algorithms.
  • To compare historical development and current outlines of treatment algorithms globally, with a focus on bipolar depression.
  • To assess the adaptability of current algorithms for individual clinical practice.

Summary:

  • The review covers the characteristics and debates concerning psychopharmacotherapy algorithms as a component of evidence-based medicine.
  • A comparative analysis of the historical evolution and international landscape of treatment algorithms, specifically for bipolar depression, is presented.

Related Experiment Videos

  • The authors emphasize that current, broadly defined algorithms can be tailored by clinicians to accommodate individual patient needs and clinical judgment.

    • Impact:

    • Provides a comprehensive overview of psychopharmacotherapy algorithms for bipolar depression.
    • Facilitates understanding of global trends and historical context in psychiatric treatment guidelines.
    • Encourages personalized medicine approaches in psychopharmacotherapy by empowering clinicians to adapt algorithms.